SFX by Ex Libris Inc.

Title:	Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome
Source:	Nature Genetics [1061-4036] Guemez Gamboa, Alicia yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ben Zvi, A. "Mfsd2a is critical for the formation and function of the bloodâbrain barrier." Nature 509.7501 (2014): 507-511.
description	2.	"Mutations in CIT, encoding citron rho-interacting serine/threonine kinase, cause severe primary microcephaly in humans." Human genetics. 135.10: 1191-1197.
description	3.	Subbaiah, Papasani V. "Enhanced incorporation of dietary DHA into lymph phospholipids by altering its molecular carrier." Biochimica et biophysica acta. Molecular and cell biology of lipids 1861.8 (2016): 723-729.
description	4.	Alakbarzade, V. "A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome." Nature Genetics 47.7 (2015): 814-7.
description	5.	Silver, David L. "Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid." Nature 509.7501 (2014): 503-506.
description	6.	Andreone, Benjamin J. "Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis." Neuron 94.3 (2017): 581-59400000.
description	7.	Armulik, A. "Pericytes regulate the blood-brain barrier." Nature 468.7323 (2010): 557-561.
description	8.	Potente, M. "Basic and therapeutic aspects of angiogenesis." Cell 146.6 (2011): 873-887.
description	9.	Pan, W. "Permeability of the blood-brain and blood spinal cord barriers to interferons." Journal of neuroimmunology 76.1-2 (1997): 105-111.
description	10.	Abbott, Adjanie A.K. J. "Structure and function of the blood-brain barrier." Neurobiology of disease 37.1 (2009): 13-25.
description	11.	"CIT, a gene involved in neurogenic cytokinesis, is mutated in human primary microcephaly." Human genetics. 135.10: 1199-1207.
description	12.	"Lipase-catalyzed synthesis of lysophospholipids in a continuous bioreactor." Oil and soap 71.1: 93-96.
description	13.	Yang, C. "Glutamine Oxidation Maintains the TCA Cycle and Cell Survival during Impaired Mitochondrial Pyruvate Transport." Molecular cell 56.3 (2014): 414-424.
description	14.	Hoshi, T. "Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+ channels." Proceedings of the National Academy of Sciences of the United States of America 110.12 (2013): 4816-4821.
description	15.	Mitchell, Grant W. "Fatty acid transport into the brain: of fatty acid fables and lipid tails." Prostaglandins, leukotrienes and essential fatty acids 85.5 (2011): 293-302.
description	16.	Rao, J S S. "n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism." Molecular psychiatry 12.1 (2006): 36-46.
description	17.	Chow, Brian W. "Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation." Neuron 93.6 (2017): 1325-1333000.
description	18.	Gabathuler, R. "Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases." Neurobiology of disease 37.1 (2010): 48-57.
description	19.	Abbott, N Joan J. "Astrocyte-endothelial interactions at the blood-brain barrier." Nature reviews. Neuroscience 7.1 (2006): 41-53.
description	20.	Carmeliet, P. "Molecular mechanisms and clinical applications of angiogenesis." Nature 473.7347 (2011): 298-307.